Bhagat K, Hingorani A, Vallance P
Heart. 1997 Jul;78(1):7-8. doi: 10.1136/hrt.78.1.7.
Dilatation of the brachial artery occurs after flow is increased, and an attenuation in this response is seen in subjects with cardiovascular risk factors, and in those with established coronary artery disease. The mechanisms linking ischaemia, flow changes, and brachial artery dilatation are unclear, and it is not known how these are affected by arterial disease. For the present it might be more appropriate to refer to flow associated rather than flow mediated dilatation, to describe the phenomenon in the brachial artery. Despite these caveats, the non-invasive measurement of brachial artery following ischaemic dilatation represents a significant advance, and its suitability as a surrogate marker for coronary artery dysfunction appears promising. The technique has potential as a tool for screening those at high risk of vascular disease, and as a surrogate endpoint in intervention studies. Further research should clarify the mechanisms involved, and lead to greater insights into the nature of endothelial dysfunction and cardiovascular disease.
肱动脉在血流量增加后会出现扩张,而在有心血管危险因素的受试者以及已确诊冠心病的患者中,这种反应会减弱。缺血、血流变化与肱动脉扩张之间的联系机制尚不清楚,也不清楚这些机制如何受到动脉疾病的影响。就目前而言,用“与血流相关的扩张”而非“血流介导的扩张”来描述肱动脉中的这一现象可能更为合适。尽管存在这些问题,但缺血后肱动脉的无创测量是一项重大进展,并且它作为冠状动脉功能障碍替代标志物的适用性似乎很有前景。该技术有潜力作为筛查血管疾病高危人群的工具,以及干预研究中的替代终点。进一步的研究应阐明其中涉及的机制,并更深入地了解内皮功能障碍和心血管疾病的本质。